- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.03. | MSD opens $1bn plant for HPV vaccine in the US | ||
| 11.03. | Pfizer's new drug data in breast cancer draws muted response | ||
| 11.03. | Scientific 'superintelligence' firm Lila launches with $200m | ||
| 11.03. | J&J abandons work with Genmab on Darzalex successor | ||
| 11.03. | NHS England facing major job losses to reduce DHSC 'overlap' | ||
| 11.03. | BMS absorbs CAR-T partner 2seventy bio for $286m | ||
| 10.03. | EU clears AZ, Ionis' Wainzua for ATTR polyneuropathy | ||
| 10.03. | Beam launches $500m financing on base-editing trial data | ||
| 10.03. | Novo Nordisk's CagriSema data disappoints investors again | ||
| 10.03. | J&J shows its confidence in oral IL-23 drug for psoriasis | ||
| 10.03. | Sun Pharma buys Checkpoint and its new cancer drug | ||
| 07.03. | Neurotech's cell therapy gets FDA nod for eye disorder MacTel | ||
| 07.03. | One of J&J's blockbuster depression hopes has flamed out | ||
| 07.03. | Denali's ALS programme suffers another setback | ||
| 07.03. | Biogen, Apple study finds smart devices can track cognition | ||
| 06.03. | FDA Commissioner pick Makary pressed by Senators on vaccines | ||
| 06.03. | Digital health firm XRHealth hits the M&A trial again | ||
| 06.03. | Trump's NIH pick closer to role as court blocks budget cuts | ||
| 06.03. | NICE agrees to look again at Alzheimer's drug Leqembi | ||
| 06.03. | Second senior NHS England executive heads for the exit | ||
| 06.03. | Novo Nordisk follows Lilly into DTC obesity drug market | ||
| 05.03. | Jazz swings further into cancer with Chimerix takeover | ||
| 05.03. | FDA starts review of Roche's Gazyva in lupus nephritis | ||
| 05.03. | Lawrence Tallon will lead MHRA after June Raine retires | ||
| 05.03. | Bayer CEO warns of tough 2025 as turnaround plan beds in |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
